CRF to release new international journal focusing on diagnosis, treatment of structural heart disease

The Cardiovascular Research Foundation (CRF) announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.

Structural Heart: The Journal of the Heart Team will publish its first issue in late Spring 2017 with submissions opening in early 2017. It will feature peer-reviewed clinical and experimental reports that focus on valvular heart disease, disorders related to the left atrial appendage, myocardial disease, congenital heart disease, and more. The journal will cover topics such as natural history and prognosis, diagnostic techniques and imaging, drug treatment, transcatheter interventions, mechanical support, cardiac surgery, and clinical trials. Regular features will include original research, clinical reviews and updates, highlights from symposia, editorial commentary, and letters. It will also publish consensus documents and white papers with recommendations on current topics in cardiovascular disease. The journal will be published by Taylor and Francis Group, LLC, part of Informa PLC, and a worldwide leader in the publication of scholarly journals, books, eBooks, text books and reference works.

"Research and treatments for structural heart disease have grown dramatically in recent years," said Anthony N. DeMaria, MD, who will serve as the Editor in Chief of Structural Heart: The Journal of the Heart Team. "For so long, our focus was on atherosclerosis and disease of the blood vessels. Among an aging population, structural heart disease has become significantly more prevalent and critical to treat for healthcare professionals. This is an important opportunity as there is no other medical journal focused on this topic."

Dr. DeMaria is the Judith and Jack White Chair in Cardiology and Founding Director of the Sulpizio Cardiovascular Center at the University of California, San Diego. He specializes in cardiac imaging techniques, particularly echocardiography. For 12 years, Dr. DeMaria served as Editor-in-Chief of the Journal of the American College of Cardiology (JACC). An author or co-author of over 700 articles in medical journals, Dr. DeMaria is also listed in the Best Doctors in America and by Good Housekeeping as one of the Best Heart Doctors in America. Dr. DeMaria is a Diplomate in the American Board of Internal Medicine and is board certified by the Subspecialty Board in Cardiovascular Disease. He is a past President of both the American College of Cardiology and American Society of Echocardiography. He has served as a member of the Subspecialty Board on Cardiovascular Disease of the American Board of Internal Medicine and Chair of the Diagnostic Radiology Study Section of the National Institutes of Health. He received his medical degree from Rutgers University, New Jersey College of Medicine and completed a medical residency at the United States Public Health Service Hospital in Staten Island, New York and cardiology fellowship training at the University of California, Davis.

"Our new journal will focus on the importance of the heart team in treating structural heart disease," said Ori Ben-Yehuda, MD, who will serve as Deputy Editor of the journal. "By providing all members of the heart team with the latest research and information in this area, we hope to impact clinical practice and patient care."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How vitamin B3 could be the secret to living longer and protecting your heart